Page 582 - Basic _ Clinical Pharmacology ( PDFDrive )
P. 582

568     SECTION V  Drugs That Act in the Central Nervous System


                 compound, fentanyl.  An extremely  potent  analog,  carfentanil,   Since each controlled-release tablet of oxycodone contains a large
                 is used in veterinary medicine for sedating large mammals, eg,   quantity of oxycodone to allow for prolonged action, those intent
                 elephants. Adulteration of street heroin with carfentanil has been   on abusing the old formulation have extracted crushed tablets and
                 responsible for many deaths in humans.              injected high doses, resulting in misuse and possible fatal overdose.
                                                                     In 2010, the FDA approved a new formulation of the controlled-
                                         O                           release form of oxycodone that reportedly prevents the tablets from
                                         C  CH 2  CH 3               being cut, broken, chewed, crushed, or dissolved to release more oxy-
                                       N
                                                                     codone. It is hoped that this new formulation will lead to less misuse
                                                                     by snorting or injection. The FDA is now requiring a Risk Evalua-
                                       N                             tion and Mitigation Strategy (REMS) that will include the issuance
                                                                     of a medication guide to patients and a requirement for prescriber
                                       CH 2  CH 2  C 6 H 5
                                      Fentanyl                       education regarding the appropriate use of opioid analgesics in the
                                                                     treatment of pain. (See Box: Educating Opioid Prescribers.)
                   These opioids differ mainly in their potency and biodisposi-
                 tion. Sufentanil is five to seven times more potent than fentanyl.               N  CH 3
                 Alfentanil is considerably less potent than fentanyl, but acts more              CH 2
                 rapidly and has a markedly shorter duration of action. Remifen-
                                                                                                  CH 2
                 tanil is metabolized very rapidly by blood and nonspecific tissue
                 esterases, making its pharmacokinetic and pharmacodynamic           H 3 C  O  O    OH
                 half-lives extremely short. Such properties are useful when these         Codeine
                 compounds are used in anesthesia practice. Although fentanyl
                 is now the predominant analgesic in the phenylpiperidine class,   Phenylheptylamines
                 meperidine continues to be used. This older opioid has signifi-  Propoxyphene is chemically related to methadone but has
                 cant antimuscarinic effects, which may be a contraindication if   extremely low analgesic activity. Its low efficacy makes it unsuit-
                 tachycardia would be a problem. Meperidine is also reported to   able,  even  in  combination  with  aspirin,  for  severe  pain.  The
                 have a negative inotropic action on the heart. In addition, it has   increasing incidence of deaths associated with its use and misuse
                 the potential for producing seizures secondary to accumulation   caused it to be withdrawn in the United States.
                 of its metabolite, normeperidine, in patients receiving high doses
                 or with concurrent renal failure. Given this undesirable profile,   Phenylpiperidines
                 use of meperidine as a first-line analgesic is becoming increas-
                 ingly rare.                                         Diphenoxylate and its metabolite, difenoxin, are not used for
                                                                     analgesia but for the treatment of diarrhea. They are scheduled
                 Morphinans                                          for minimal control (difenoxin is Schedule IV, diphenoxylate
                                                                     Schedule V; see inside front cover) because the likelihood of their
                 Levorphanol is a synthetic opioid analgesic closely resembling   misuse is remote. The poor solubility of the compounds limits
                 morphine that has μ-, δ-, and κ-opioid agonist actions, serotonin-  their use for parenteral injection. As antidiarrheal drugs, they are
                 norepinephrine reuptake inhibition, and NMDA receptor antago-  used in combination with atropine. The atropine is added in a
                 nist properties.                                    concentration too low to have a significant antidiarrheal effect but
                                                                     is presumed to further reduce the likelihood of misuse.
                 MILD TO MODERATE AGONISTS                              Loperamide is a phenylpiperidine derivative used to control
                                                                     diarrhea. Due to action on peripheral  μ-opioid receptors and
                 Phenanthrenes                                       lack of effect on CNS receptors, investigations are ongoing as to
                                                                     whether it could be an effective analgesic. Its potential for misuse
                 Codeine, dihydrocodeine, and  hydrocodone have lower   is considered very low because of its limited access to the brain. It
                 binding affinity to μ-opioid receptors than morphine and often   is therefore available without a prescription.
                 have adverse effects that limit the maximum tolerated dose   The usual dose with all of these antidiarrheal agents is two
                 when one attempts to achieve analgesia comparable to that of   tablets to start and then one tablet after each diarrheal stool.
                 morphine.
                   Oxycodone is more potent and is prescribed alone in higher
                 doses as immediate-release or controlled-release forms for the   OPIOIDS WITH MIXED RECEPTOR
                 treatment of moderate to severe pain. Combinations of hydro-  ACTIONS
                 codone or oxycodone with acetaminophen are the predominant
                 formulations of orally administered analgesics in the United States   Care should be taken not to administer any partial agonist or drug
                 for the treatment of mild to moderate pain. However, there has   with mixed opioid receptor actions to patients receiving pure ago-
                 been a large increase in the use of controlled-release oxycodone at   nist drugs because of the unpredictability of both drugs’ effects;
                 the highest dose range. An intravenous formulation of oxycodone   reduction of analgesia or precipitation of an explosive abstinence
                 is available outside the United States.             syndrome may result.
   577   578   579   580   581   582   583   584   585   586   587